Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$272M |
| 2 |
Chevron
CVX
|
+$206M |
| 3 |
Tesla
TSLA
|
+$153M |
| 4 |
NVIDIA
NVDA
|
+$143M |
| 5 |
Pfizer
PFE
|
+$131M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$242M |
| 2 |
First Solar
FSLR
|
+$153M |
| 3 |
Walmart Inc
WMT
|
+$133M |
| 4 |
Steel Dynamics
STLD
|
+$115M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.92% |
| 2 | Financials | 15.55% |
| 3 | Industrials | 13.68% |
| 4 | Consumer Discretionary | 11.04% |
| 5 | Healthcare | 10.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2076
Iovance Biotherapeutics
IOVA
$1.93B
| $14.8M | ﹤0.01% |
2,097,003
+587,770
| +39% | +$4.21M |
|
2077
Companhia Siderúrgica Nacional
SID
$1.23B
| $14.7M | ﹤0.01% |
5,666,128
-126,900
| -2% | -$350K |
|
|
CNSL
2078
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $14.7M | ﹤0.01% |
3,836,944
-267,198
| -7% | -$963K |
|
2079
Timberland Bancorp
TSBK
$353M
| $14.7M | ﹤0.01% |
574,221
-14,805
| -3% | -$370K |
|
2080
nCino
NCNO
$2.1B
| $14.6M | ﹤0.01% |
+486,250
| New | +$12.4M |
|
2081
nLIGHT
LASR
$3.95B
| $14.6M | ﹤0.01% |
949,549
+135,318
| +17% | +$1.65M |
|
2082
Relay Therapeutics
RLAY
$4.09B
| $14.6M | ﹤0.01% |
1,164,386
-71,409
| -6% | -$888K |
|
2083
First Mid Bancshares
FMBH
$1.4B
| $14.6M | ﹤0.01% |
605,564
+14,647
| +2% | +$365K |
|
2084
Commercial Vehicle Group
CVGI
$156M
| $14.6M | ﹤0.01% |
1,312,972
+65,437
| +5% | +$594K |
|
2085
Editas Medicine
EDIT
$407M
| $14.5M | ﹤0.01% |
1,767,229
+155,476
| +10% | +$1.35M |
|
2086
Olema Pharmaceuticals
OLMA
$985M
| $14.5M | ﹤0.01% |
1,602,556
+1,389,244
| +651% | +$8.39M |
|
2087
Utah Medical Products
UTMD
$232M
| $14.5M | ﹤0.01% |
155,127
+589
| +0.4% | +$55.5K |
|
2088
Adaptive Biotechnologies
ADPT
$3.68B
| $14.4M | ﹤0.01% |
2,149,946
+501,585
| +30% | +$3.73M |
|
2089
Remitly
RELY
$5.05B
| $14.4M | ﹤0.01% |
762,790
+518,315
| +212% | +$9.42M |
|
2090
CNB Financial Corp
CCNE
$1.05B
| $14.3M | ﹤0.01% |
811,819
+16,035
| +2% | +$287K |
|
|
MCBC
2091
DELISTED
Macatawa Bank Corp
MCBC
| $14.3M | ﹤0.01% |
1,539,310
+3,709
| +0.2% | +$34.4K |
|
2092
Marqeta
MQ
$1.88B
| $14.3M | ﹤0.01% |
732,971
+31,478
| +4% | +$571K |
|
2093
Tradeweb Markets
TW
$21.5B
| $14.2M | ﹤0.01% |
207,773
+15,102
| +8% | +$1.07M |
|
|
MODN
2094
DELISTED
MODEL N, INC.
MODN
| $14.2M | ﹤0.01% |
402,002
+38,712
| +11% | +$1.24M |
|
2095
Nomura Holdings
NMR
$28B
| $14.2M | ﹤0.01% |
3,700,201
-12,170
| -0.3% | -$45.1K |
|
2096
Oscar Health
OSCR
$9.27B
| $14.2M | ﹤0.01% |
1,757,086
+1,200,156
| +215% | +$8.85M |
|
2097
Farmers National Banc Corp
FMNB
$946M
| $14.2M | ﹤0.01% |
1,144,873
+23,408
| +2% | +$279K |
|
2098
DigitalOcean
DOCN
$14.9B
| $14.1M | ﹤0.01% |
350,942
+69,680
| +25% | +$2.57M |
|
2099
Hingham Institution for Saving
HIFS
$647M
| $14.1M | ﹤0.01% |
66,063
+5,735
| +10% | +$1.17M |
|
2100
BioLife Solutions
BLFS
$1.57B
| $14.1M | ﹤0.01% |
636,602
+148,327
| +30% | +$3.12M |
|
Similar funds
Dimensional Fund Advisors's Q2 2023 Portfolio in Review
As of Q2 2023, Dimensional Fund Advisors held 3,572 positions worth $314B, up 5.7% from $297B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Dimensional Fund Advisors's Q2 2023 filing shows 111 new, 1,840 increased, 1,366 reduced and 91 closed positions. Its largest new stake was Knife River: 1,268,239 shares worth $55.2M. The largest sale was Apple, an estimated $242M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q2 2023 buy was Knife River: 1,268,239 shares worth $55.2M.
- Dimensional Fund Advisors added most to ExxonMobil in Q2 2023, an estimated $272M increase.
- Dimensional Fund Advisors's biggest Q2 2023 reduction was Apple, cutting an estimated $242M.
- Dimensional Fund Advisors fully exited Maxar Technologies Inc. Common Stock in Q2 2023, selling an estimated $102M.
- Dimensional Fund Advisors's ten largest holdings make up 12% of its $314B portfolio in Q2 2023.
- Dimensional Fund Advisors opened 111 new positions and closed 91 in Q2 2023.
- Dimensional Fund Advisors's portfolio value rose 5.7% quarter-over-quarter to $314B.
Based on Dimensional Fund Advisors's 13F filing for Q2 2023, filed 9 Aug 2023.